Healthcare & Life Sciences
Dendreon
United Statesdendreon.com
Dendreon is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Dendreon
Dendreon is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Dendreon develops and manufactures cellular immunotherapies, including Provenge, the first FDA-approved cellular immunotherapy for prostate cancer.
Explore Dendreon's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.